REG-The Vanguard Group Rule 8.3 - Inverness Med. Innovation

LONDON--(Business Wire)--

FORM 8.3

DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE

(Rule 8.3 of the Takeover Code)

1.KEY INFORMATION

Name of person dealing (Note 1) The Vanguard Group, Inc.
Company dealt in Inverness Medical Innovations, Inc.
Class of relevant security to which the dealings being disclosed relate (Note 2) Common Stock - ISIN US46126P1066
Date of dealing 06/26/2009

2.INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE

(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)

Long Short
Number (%) Number (%)
(1) Relevant securities 2,453,237 3.12%
(2) Derivatives (other than options) 0
(3) Options and agreements to purchase/sell 0
Total 2,453,237 3.12%

(b)Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

(c)Rights to subscribe (Note 3)

Class of relevant security: Details

3.DEALINGS (Note 4)

(a)Purchases and sales

Purchase/sale Number of securities Price per unit (Note 5)
Purchase 400 $ 35.34
Purchase 3085 $ 35.35
Sell 338 $ 35.35

(b)Derivatives transactions (other than options)

Product name, Long/short (Note 6) Number of securities (Note 7) Price per unit (Note 5)
e.g. CFD

(c)Options transactions in respect of existing securities

(i)Writing, selling, purchasing or varying

Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise Type, e.g. American, European etc. Expiry Option money
e.g. call option price date paid/received per unit (Note 5)

(ii)Exercising

Product name, e.g. call option Number of securities Exercise price per unit (Note 5)

(d)Other dealings (including new securities) (Note 4)

Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5)

4.OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9) NO

Date of disclosure 06/29/2009
Contact name James Conrad
Telephone number 610-669-3098
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel`s website at
www.thetakeoverpanel.org.uk

The Vanguard Group

Copyright Business Wire 2009